Page last updated: 2024-12-07

5-methoxymethyl-2'-deoxyuridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-methoxymethyl-2'-deoxyuridine (also known as M(m)dUrd or 5-MOMdUrd) is a synthetic nucleoside analog that is an inhibitor of thymidylate synthase (TS). It is an effective anticancer agent that has been shown to be active against a variety of human cancers, including leukemia, lymphoma, and breast cancer. 5-MOMdUrd is a prodrug that is converted to its active form, 5-methoxymethyl-2'-deoxyuridine 5'-monophosphate (M(m)dUMP), by the enzyme thymidine kinase. M(m)dUMP is a potent inhibitor of TS, which is an essential enzyme for the biosynthesis of thymidine. By inhibiting TS, 5-MOMdUrd prevents the formation of thymine, a key component of DNA. This ultimately leads to the inhibition of DNA synthesis and cell proliferation. 5-MOMdUrd is being studied for its potential as an anticancer agent. It is currently in clinical trials for the treatment of various types of cancer. In addition to its anticancer activity, 5-MOMdUrd has also been shown to have antiviral activity. It is active against a variety of viruses, including herpes simplex virus, varicella-zoster virus, and cytomegalovirus. 5-MOMdUrd is being investigated as a potential treatment for viral infections. Research on 5-MOMdUrd is ongoing to better understand its mechanism of action and to develop new therapeutic applications.'
```

5-methoxymethyl-2'-deoxyuridine: used in treatment of experimental herpes simplex keratitis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID119051
SCHEMBL ID8191817
MeSH IDM0083247

Synonyms (19)

Synonym
mmdurd
mmudr
5-methoxymethyl-2'-deoxyuridine
1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(methoxymethyl)pyrimidine-2,4-dione
methoxymethyl deoxyuridine
alpha-methoxythymidine
thymidine, alpha-methoxy-
2'-deoxy-5-(methoxymethyl)uridine
5-methoxymethyldeoxyuridine
uracil, 1-(2-deoxy-beta-d-erythro-pentofuranosyl)-5-(methoxymethyl)-
2'-deoxy-5-methoxymethyluridine
1-(2-deoxy-beta-d-ribofuranosyl)-5-methoxymethyluracil
uridine, 2'-deoxy-5-methoxymethyl-
5116-22-3
1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(methoxymethyl)pyrimidine-2,4-dione
BRD-K68812989-001-01-5
SCHEMBL8191817
DTXSID00199185
1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-(methoxymethyl)pyrimidine-2,4(1h,3h)-dione
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (92.86)18.7374
1990's1 (7.14)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.50 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]